Clinicians frequently reach out to Catherine Varney, DO, asking if it’s safe to prescribe glucagon-like peptide 1 receptor ...

Newer glucose-lowering drugs reduce the risk for late-onset seizures and epilepsy by 24%, with GLP-1 RAs cutting the risk by ...

Bryan Johnson, the tech entrepreneur and millionaire who became famous for infusing his son’s plasma into his blood in an ...

While appreciating diet and exercise, scientists note that they failed to tide on the obesity pandemic and that GLP-1 RAs ...

Researchers have discovered that sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) reduce the risk for clinically important kidney and cardiovascular disease outcomes in individuals with type 2 diabetes.

"An MDL that encompassed any potential injury relating to use of these exceedingly popular weight loss drugs might quickly ...

Bryan Johnson, the tech entrepreneur and millionaire who became famous for infusing his son’s plasma into his blood in an ...

The global obesity epidemic represents one of the most pressing public health challenges of our time. With nearly ...

New research found that some anti-obesity medications such as Wegovy and Zepbound may prompt people to drink less. These ...